Skip to content

Rotational Thromboelastometry Guided Blood Component versus conventional blood product transfusion to prevent bleeding in children with liver involvement undergoing invasive tests

Rotational Thromboelastometry( ROTEM) Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029132
Enrollment
60
Registered
2020-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

Intervention1: Rotational Thromboelastometry: To prevent bleeding during invasive procedure, cirrhotic children in the ROTEM group will receive prophylactic transfusion based on the following protocol

Sponsors

ILBS hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children less than 18 years of age with histologic or image proven liver cirrhosis of any etiology with INR � 1.5- � 2.5 and/or PLT count 20,000/mm3- 50,000/mm3 and who are listed for the following invasive procedures : Low risk of bleeding Central venous cannulation Haemodialysis catheter Ascitic or Pleural tapping EVL EST High risk of bleeding TIPPS ERCP with sphicterotomy PCD Insertion Biopsies other than liver biopsy AND Children less than 18 years of age with histologic or image proven liver cirrhosis of any etiology with INR � 1.5- � 2.0 and/or PLT count 40,000/mm3- 60,000/mm3 and who are listed for Liver biopsy

Exclusion criteria

Exclusion criteria: Anti platelet or anti coagulant therapy in the previous 7 days Patients with clinical evidence of DIC and/or active bleeding Hemodialysis in the past 7 days

Design outcomes

Primary

MeasureTime frame
Comparison in the amount of blood products transfused between the groups To compare the amount of total component transfused (ml/kg) in Rotational Thromboelastometry guided therapy versus Conventional therapy for invasive procedures in children with cirrhosis To compare the amount of total component transfused (ml/kg) in Rotational Thromboelastometry guided therapy versus Conventional therapy for invasive procedures in children with cirrhosisTimepoint: 24 hours

Secondary

MeasureTime frame
Post-procedure bleeding Comparison of the number of patients having bleeding episodes after procedure between the study groupsTimepoint: 24 hours;Transfusion related side effects - To compare the rate of transfusion reactions in Rotational Thromboelastometry guided therapy versus Conventional therapy for invasive procedures in children with cirrhosisTimepoint: 5 days;Comparison between blood products costs between groups To compare the cost of transfusion components incurred in Rotational Thromboelastometry guided therapy versus Conventional therapy for invasive procedures in children with cirrhosisTimepoint: 24 hours;Comparison in the amount of Cryoprecipitate transfused between the groups To compare the amount of Cryoprecipitate transfused in Rotational Thromboelastometry guided therapy versus Conventional therapy for invasive procedures in children with cirrhosisTimepoint: 24 hours;Comparison in the amount of FFP transfused between the groups To compare the amount of FFP (ml/kg) transfused in Rotational Thromboelastometry guided therapy versus Conventional therapy for invasive procedures in children with cirrhosisTimepoint: 24 hours;Comparison in the amount of Platelet transfused between the groups To compare the amount of Platelet transfused in Rotational Thromboelastometry guided therapy versus Conventional therapy for invasive procedures in children with cirrhosisTimepoint: 24 hours

Countries

India

Contacts

Public ContactArjun Maria

ILBS, Delhi

seema_alam@hotmail.com9540951008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026